Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-ITNK Cells for Refractory B Cell Malignancies
NCT04747093Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAR-ITNK in B-cell leukemia (BCL), B cell lymphoma, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
CAR-ITNK
03
Conditions
B-cell leukemia (BCL)B cell lymphoma
Beyond the preview
Go deeper on NCT04747093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747093.